secwatch.observer — SEC 8-K summary
======================================

Issuer:     BlossomHill Therapeutics, Inc. (BLSM)
CIK:        0001839970
Form:       8-K
Filed at:   2026-08-10T20:01:18+00:00
Accession:  0001193125-26-342316
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BlossomHill Therapeutics completes IPO of 9.375M shares at $16.00, gross proceeds ~$150M
--------------------------------------------------------------------------------

- IPO closed Aug 10, 2026; 9,375,000 shares sold at $16.00 per share.
- Gross proceeds approximately $150.0M before underwriting discounts and expenses.
- Amended and restated certificate of incorporation and bylaws effective Aug 10, 2026.
- Stock trades on Nasdaq Global Select Market under ticker BLSM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839970/000119312526342316/0001193125-26-342316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839970/000119312526342316/d138762d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-342316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer